Disease: Optic pathway glioma
- A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy <em>in vivo</em>
- A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
- A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences
- A novel stop-gain <em>NF1</em> variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas
- A novel stop-gain NF1 variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas
- A sellar-suprasellar malignant optic pathway glioblastoma in the absence of prior radiation therapy: illustrative case
- Acquired myelinated retinal nerve fiber layer in a child with neurofibromatosis 1-related optic pathway glioma
- Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
- An Isolated Case of Unilateral Macro-Ophthalmia With Resultant Anisometropic Amblyopia in Neurofibromatosis 1
- An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome
- Anti-seizure effect of MEK inhibitor in a child with neurofibromatosis type 1 - developmental and epileptic encephalopathy and optic pathway glioma
- Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma
- Arterial spin labelling: predictive role in surgical bleeding of paediatric optic pathway gliomas
- Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging
- Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma
- Bilateral visual pathway invasion of occipital astrocytoma: a case report
- Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?
- Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country
- Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages
- Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey
- Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1
- Comparison of MRI findings of hypothalamic-optic chiasmatic gliomas and craniopharyngiomas
- Complications and visual outcomes following surgical resection of pediatric optic pathway/hypothalamic gliomas: a systematic review and meta-analysis
- Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution
- Corrigendum to: Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back
- Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy <em>in vivo</em>
- Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
- Cost Analysis of Orthoptist-Led Neurofibromatosis Type 1 Screening Clinics
- Cudraflavone B induces human glioblastoma cells apoptosis via ER stress-induced autophagy
- Deficits in naming pictures of objects are associated with glioma infiltration of the inferior longitudinal fasciculus: A study with diffusion MRI tractography, volumetric MRI, and neuropsychology
- DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
- Effectiveness of Gold Nanorods of Different Sizes in Photothermal Therapy to Eliminate Melanoma and Glioblastoma Cells
- Effects of octadecadienoic acid on proliferation and apoptosis of glioma cells and its mechanisms
- Endoscopic debulking canalization for optic pathway glioma with obstructive hydrocephalus
- Endoscopic Endonasal Transcavernous Posterior Clinoidectomy With Interdural Pituitary Transposition for a Suprasellar Optic Pathway Pilocytic Astrocytoma: 2-Dimensional Operative Video
- Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience
- Estrogen-induced glial IL-1beta mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma
- Estrogen-induced glial IL-1β mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma
- Evaluation of Pathway to Diagnosis of Pediatric Brain Tumors in Tamil Nadu, India
- Excessive Lipid Production Shapes Glioma Tumor Microenvironment
- G protein inhibitory alpha subunit 2 is a molecular oncotarget of human glioma
- Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas
- Imaging glymphatic response to glioblastoma
- Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas
- Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1
- Intraoperative Neuromonitoring of the Visual Pathway in Asleep Neuro-Oncology Surgery
- Is proton beam therapy always better than photon irradiation? Lessons from two cases
- Laser interstitial thermal therapy is effective and safe for the treatment of brain tumors in NF1 patients after cerebral revascularization for moyamoya angiopathy: a report on two cases
- Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
- Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions
- Magnetic resonance imaging characteristics of glioblastoma of the optic pathway during adulthood
- Meningeal macrophages inhibit chemokine signaling in pre-tumor cells to suppress mouse medulloblastoma initiation
- Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-kappaB activity
- Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review
- Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
- Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments
- Neurosurgical management of proton beam therapy-induced moyamoya syndrome
- Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies
- NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma
- Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes
- Ophthalmologic Findings in Children with Neurofibromatosis Type 1
- Optic Pathway Gliomas in Pediatric Population-Current Approach in Diagnosis and Management: Literature Review
- Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function
- Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation
- Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis
- Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse
- Pediatric Optic Pathway Gliomas: A Report From Northern Greece
- Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group
- Phenotype and Genotype of Saudi Pediatric Patients With Neurofibromatosis Type 1: A Seven-Year Multicenter Experience From Saudi Arabia
- Photobiomodulation Recovers the Submandibular Gland in Vismodegib-Treated Rats
- Pilocytic Astrocytoma
- Pilose antler extract promotes hair growth in androgenic alopecia mice by promoting the initial anagen phase
- Prechiasmatic Transection of the Unilateral Dodge Class Ⅰ Optic Pathway Glioma without Neurofibromatosis Type 1: Technical Description and Clinical Prognosis
- Prechiasmatic Transection of the Unilateral Dodge Class Optic Pathway Glioma without Neurofibromatosis Type 1: Technical Description and Clinical Prognosis
- Prechiasmatic transection of the unilateral Dodge ClassesⅠoptic pathway glioma (OPG-uDCⅠ) without neurofibromatosis type 1 (NF1): technical description and clinical prognosis
- Primary anterior visual pathway germinoma in a 13-year-old boy: A case report
- Recent advances in label-free optical, electrochemical, and electronic biosensors for glioma biomarkers
- Simulated microgravity induces DNA damage concurrent with impairment of DNA repair and activation of cell-type specific DNA damage response in microglial and glioblastoma cells
- Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma
- Sonoporation-assisted micelle delivery in subcutaneous glioma-bearing mice evaluated by PET/fluorescent bi-modal imaging
- Spontaneous regression of tumor in a girl with optic pathway glioma with diencephalic syndrome
- Standardization of Strategies to Perform a Parafascicular Tubular Approach for the Resection of Brain Tumors in Eloquent Areas
- The Endonasal Endoscopic Transsphenoidal Approach to Paediatric Optic Chiasma Glioma: A Case Report and Literature Review
- The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis
- The management of neurofibromatosis type 1 (NF1) in children and adolescents
- The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma
- The Present and Future of Optic Pathway Glioma Therapy
- The rare case of optic nerve cavernoma: A case report depicting the diagnostic challenge
- The Relationship Between Choroidal Abnormalities and Visual Outcomes in Pediatric Patients With NF1-Associated Optic Pathway Gliomas
- The Role Gut Microbiota in Glaucoma Progression and Other Retinal Diseases
- The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases
- The role of visual electrodiagnostics in management of children with neurofibromatosis type 1
- Transorbital neuroendoscopy-assisted resection of a giant optic pathway glioma in a neonate
- Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components
- Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome
- Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology
- Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal Tumors
- Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
- Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
- Visual outcomes after bevacizumab-based therapy for optic pathway glioma